tradingkey.logo
tradingkey.logo
Search

Accuray Inc

ARAY
Add to Watchlist
0.270USD
-0.015-5.20%
Close 05/15, 16:00ETQuotes delayed by 15 min
32.11MMarket Cap
LossP/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-5.20%

5 Days

-28.95%

1 Month

-39.35%

6 Months

-74.04%

Year to Date

-67.26%

1 Year

-83.33%

TradingKey Stock Score of Accuray Inc

Currency: USD Updated: 2026-05-15

Key Insights

Accuray Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 85 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 1.18.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Accuray Inc's Score

Industry at a Glance

Industry Ranking
85 / 206
Overall Ranking
206 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Accuray Inc Highlights

StrengthsRisks
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Overvalued
The company’s latest PE is -0.71, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 85.92M shares, decreasing 3.71% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 287.16K shares of this stock.

Analyst Rating

Based on 2 analysts
Hold
Current Rating
1.175
Target Price
+312.57%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Accuray Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Accuray Inc Info

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Ticker SymbolARAY
CompanyAccuray Inc
CEOLa Neve (Stephen R)
Websitehttps://www.accuray.com/
KeyAI